A signature for immune response correlates with HCV treatment outcome in Caucasian subjects

Area of Science:

• Proteomics
• Virology
• Biomarker Discovery

Background:

• Hepatitis C virus (HCV) infection poses a significant global health challenge.
• Predicting treatment outcomes in HCV patients is crucial for personalized medicine.
• Whole-blood proteomic signatures offer a promising avenue for developing predictive biomarkers.

Purpose of the Study:

• To provide supplementary data for a study identifying a whole-blood proteomic signature for predicting HCV treatment outcomes.
• To detail the experimental and computational methodologies employed in the proteomic analysis.
• To present comprehensive results, including protein lists and predictive model performance metrics.

Main Methods:

• Whole-blood samples were collected from HCV-infected subjects.
• Proteomic analysis was performed to identify potential biomarkers.
• Computational methods, including regression modeling and ROC curve analysis, were used to develop and validate the predictive signature.

Main Results:

• A specific proteomic signature in whole blood was identified.
• The signature demonstrated predictive capability for treatment outcomes in HCV patients.
• Detailed lists of identified proteins and regression model coefficients are provided.

Conclusions:

• The identified whole-blood proteomic signature serves as a valuable tool for predicting HCV treatment response.
• This data article supports the clinical utility of proteomic biomarkers in managing HCV infection.
• Further research can build upon these findings for improved patient management strategies.